News

Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart. Here, we look at the latest noteworthy upgrades and downgrades of stocks made by analysts.

Home Depot is scheduled to report fourth-quarter earnings before the bell on Tuesday, with analysts expecting rising sales to have risen despite projecting comparable store sales to have declined for a ninth consecutive quarter.

U.S. Securities and Exchange Commission has decided to withdraw its appeal of a decision by a federal judge late last year to vacate an overhaul of Treasury dealer rules, according to a court document filed on Wednesday. In a statement, the SEC said it decided to dismiss the appeal because the new rule could reduce "liquidity in the Treasury markets, making them more volatile, and increasing debt for taxpayers." One year ago, the SEC under Chair Gary Gensler adopted a rule requiring proprietary traders and other firms that routinely deal in U.S. government bonds to register as broker-dealers, subjecting them to stricter oversight.

The outsized swings in markets on the back of Donald Trump's every word on tariffs just weeks ago have faded to mere flickers, as investors switch their focus elsewhere, and bet against a full-scale trade war really materialising. China is one of the few trading partners on which Trump has increased tariffs, but Hong Kong's Hang Seng index is up 14% year to date, led by a surge in tech stocks. Similarly, traders are banking on less volatility in the Canadian dollar and Mexican peso - both slightly stronger than they were at the start of the year - and an index of European auto stocks - also vulnerable to tariffs - hit a seven-month high this week.

Shares of health and wellness products company Herbalife (NYSE:HLF) jumped 44.6% in the afternoon session after the company reported impressive fourth-quarter results, which blew past analysts' EPS and EBITDA estimates. On the other hand, revenue guidance for the next quarter missed expectations, with sales projected to decline between 5.5% and 1.5% y/y. Full-year EBITDA guidance also fell short of Wall Street's estimates, raising concerns about the company's ability to sustain its margins and p

Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 9.6% in the pre-market session after the company reported impressive fourth-quarter results, exceeding analysts' sales and EPS estimates. Total revenue grew 16% y/y fueled by strong demand for Voxzogo, which saw a 42% jump in sales, and a steady 9% increase in its Enzyme Therapies segment​. Improved profitability also played a key role, with GAAP net income soaring more than fivefold. Looking ahead, management expects another

Shares of online used car auction platform ACV Auctions (NASDAQ:ACVA) fell 9.2% in the pre-market session after the company reported weak fourth-quarter results, and provided full-year revenue and EBITDA guidance below Wall Street's estimates. The outlook assumes a flat dealer wholesale market, which may limit upside potential in the near term. In addition, margins deteriorated and the company burned cash during the quarter. On the other hand, ACVA blew past analysts' EBITDA expectations this qu